Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elecoglipron in Asian Participants With Obesity or Overweight
NCT07775404Phase 3Recruiting
- Sponsor
- AstraZeneca
- Start
- Aug 2026
- Primary completion
- Apr 2028
- Countries
- 5
01
Overview
A Phase 3 trial of elecoglipron in obesity, sponsored by AstraZeneca. Started Aug 2026; status: recruiting.
02
Drugs
elecoglipron
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07775404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775404.